The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Aminoglycoside Resistance
Open accessAbstract
Aminoglycoside-producing Actinobacteria are known to protect themselves from their own aminoglycoside metabolites by producing 16S ribosomal RNA methyltransferase (16S-RMTase), which prevents them from binding to the 16S rRNA targets. Ten acquired 16S-RMTases have been reported from gram-negative pathogens. Most of them posttranscriptionally methylate residue G1405 of 16S rRNA resulting in high-level resistance to gentamicin, tobramycin, amikacin, and plazomicin. Strains that produce 16S-RMTase are frequently multidrug-resistant or even extensively drug-resistant. Although the direct clinical impact of high-level aminoglycoside resistance resulting from production of 16S-RMTase is yet to be determined, ongoing spread of this mechanism will further limit treatment options for multidrug-resistant and extensively drug-resistant gram-negative infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Aminoglycoside modifying enzymes
Ramirez, M. S., & Tolmasky, M. E. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.08.003 · Cited by 1,464
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Epstein, L., Hunter, J. C., Arwady, M. A., Tsai, V., Stein, L., Gribogiannis, M., Frias, M., Guh, A. Y., Laufer, A. S., Black, S., et al. (2014) · JAMA · doi:10.1001/jama.2014.12720 · Cited by 400
Galimand, M., Courvalin, P., & Lambert, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2565-2571.2003 · Cited by 350
Wachino, J., & Arakawa, Y. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.05.001 · Cited by 255
Self-citationAcquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa
Yokoyama, K., Doi, Y., Yamane, K., Kurokawa, H., Shibata, N., Shibayama, K., Yagi, T., Kato, H., & Arakawa, Y. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14959-8 · Cited by 242
Self-citationGalimand, M., Sabtcheva, S., Courvalin, P., & Lambert, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2949-2953.2005 · Cited by 209
Gniadkowski, M., Schneider, I., Pałucha, A., Jungwirth, R., Mikiewicz, B., & Bauernfeind, A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.827 · Cited by 198
Doi, Y., Yokoyama, K., Yamane, K., Wachino, J.-I., Shibata, N., Yagi, T., Shibayama, K., Kato, H., & Arakawa, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.491-496.2004 · Cited by 187
Self-citationPhylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases
Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M., & Woodford, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr226 · Cited by 182
Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides
Beauclerk, A. A. D., & Cundliffe, E. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90349-4 · Cited by 181
Wachino, J.-I., Shibayama, K., Kurokawa, H., Kimura, K., Yamane, K., Suzuki, S., Shibata, N., Ike, Y., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00926-07 · Cited by 180
Self-citationWright, M. S., Haft, D. H., Harkins, D. M., Perez, F., Hujer, K. M., Bajaksouzian, S., Benard, M. F., Jacobs, M. R., Bonomo, R. A., & Adams, M. D. (2014) · mBio · doi:10.1128/mbio.00963-13 · Cited by 165
Rahman, M., Shukla, S. K., Prasad, K. N., Ovejero, C. M., Pati, B. K., Tripathi, A., Singh, A., Srivastava, A. K., & Gonzalez-Zorn, B. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.03.003 · Cited by 159
Gołębiewski, M., Kern-Zdanowicz, I., Zienkiewicz, M., Adamczyk, M., Żylińska, J., Baraniak, A., Gniadkowski, M., Bardowski, J. K., & Cegłowski, P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00457-07 · Cited by 155
Evolution of IncA/C bla CMY-2 -Carrying Plasmids by Acquisition of the bla NDM-1 Carbapenemase Gene
Carattoli, A., Villa, L., Poirel, L., Bonnin, R. A., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05116-11 · Cited by 151
Fritsche, T. R., Castanheira, M., Miller, G. H., Jones, R. N., & Armstrong, E. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01477-07 · Cited by 143
Chen, L., Zhang-liu, C., Liu, J., Zeng, Z., Ma, J., & Jiang, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm065 · Cited by 130
Ramos, P. I. P., Picão, R. C., de Almeida, L. G. P., Lima, N. C. B., Girardello, R., Vivan, A. C. P., Xavier, D. E., Barcellos, F. G., Pelisson, M., Vespero, E. C., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-54 · Cited by 127
Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States
Adams‐Haduch, J. M., Onuoha, E. O., Bogdanovich, T., Tian, G., Marschall, J., Urban, C. M., Spellberg, B. J., Rhee, D., Halstead, D. C., Pasculle, A. W., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00619-11 · Cited by 127
Self-citationDiscovery of a Gene Conferring Multiple-Aminoglycoside Resistance in Escherichia coli
Davis, M. A., Baker, K. N. K., Orfe, L. H., Shah, D. H., Besser, T. E., & Call, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01743-09 · Cited by 114
Hidalgo, L., Hopkins, K. L., Gutiérrez‐Gutiérrez, B., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt078 · Cited by 112
Bueno, M. F. C., Francisco, G. R., O’Hara, J. A., Garcia, D. D. O., & Doi, Y. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02108-12 · Cited by 109
Self-citationCooksey, R. C., Morlock, G. P., McQueen, A., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1186 · Cited by 107
Aminoglycoside Resistance by ArmA-mediated Ribosomal 16S Methylation in Human Bacterial Pathogens
Liou, G. F., Yoshizawa, S., Courvalin, P. M., & Galimand, M. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.03.038 · Cited by 104
Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland
Poirel, L., Schrenzel, J., Cherkaoui, A., Bernabeu, S., Renzi, G., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr174 · Cited by 101
Sidjabat, H. E., Townell, N., Nimmo, G. R., George, N., Robson, J. M. B., Vohra, R., Davis, L., Heney, C., & Paterson, D. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04378-14 · Cited by 88
RmtF, a New Member of the Aminoglycoside Resistance 16S rRNA N7 G1405 Methyltransferase Family
Galimand, M., Courvalin, P. M., & Lambert, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00660-12 · Cited by 83
Doi, Y., Hazen, T. H., Boitano, M., Tsai, Y., Clark, T. A., Korlach, J., & Rasko, D. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03180-14 · Cited by 71
Self-citationDunkle, J. A., Vinal, K., Desai, P. M., Zelinskaya, N. V., Savić, M., West, D. M., Conn, G. L., & Dunham, C. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402789111 · Cited by 64
Berçot, B., Poirel, L., & Nordmann, P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00882-08 · Cited by 50
AL-SHEIKH, Y. A., Marie, M. A. M., John, J., Krishnappa, L. G., & Dabwan, K. H. M. (2014) · Libyan Journal of Medicine · doi:10.3402/ljm.v9.24432 · Cited by 39
Epson, E. E., Pisney, L. M., Wendt, J. M., MacCannell, D., Janelle, S. J., Kitchel, B., Rasheed, J. K., Limbago, B. M., Gould, C. V., Kallen, A. J., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675607 · Cited by 38
Tijet, N., Andres, P. O., Chung, C., Lucero, C., Low, D. E., Galas, M., Corso, A. C., Petroni, A., & Melano, R. G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00962-10 · Cited by 34
Cited by
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance
Navon-Venezia, S., Kondratyeva, K., & Carattoli, A. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux013 · Cited by 1,286
Peterson, E., & Kaur, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02928 · Cited by 1,006
Antimicrobial Resistance in Escherichia coli
Poirel, L., Madec, J.-Y., Lupo, A., Schink, A.-K., Kieffer, N., Nordmann, P., & Schwarz, S. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0026-2017 · Cited by 876
Metadata
- Authors
- Doi, Y., Wachino, J.-I., & Arakawa, Y.
- Venue
- Infectious Disease Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 30
- Issue
- 2
- Pages
- 523-537
- ISSN
- 0891-5520 (ISSN-L)
- OpenAlex
- W2408536099
- Cited by
- 341
- References
- 37
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.